MEDC Press Releases
Monday, December 19, 2022
Governor Whitmer Announces Carhartt, Family-Owned Manufacturer of Workwear and Outdoor Apparel, Expanding in Dearborn to Create 125 jobs
Read MoreFriday, December 16, 2022
Gov. Whitmer Announces Transportation Engineering Firm HNTB Corporation Creating up to 165 High-Wage jobs in Detroit, East Lansing
Read MoreWednesday, December 14, 2022
This Just In: State Approves Additional Funding to Support Industry 4.0 Technology Adoption by Manufacturers Statewide
Read MoreTuesday, December 13, 2022
Gov. Whitmer Wins Major Economic Deals, Creating or Retaining 1,846 Jobs, Generating Over $1.2 Billion in Investments
Read MoreMonday, December 12, 2022
Governor Whitmer Awards Funding to Support 35 Local Small Businesses Around the State Through Match on Main Grant Program
Read MoreThursday, December 8, 2022
Village of Cass City receives Certification as Redevelopment Ready Community
Designation facilitates private investment, improves economic development opportunities
Read MoreThursday, December 8, 2022
Governor Whitmer Announces $2 Million Grant to Grow High-Tech Talent Pipeline in Michigan
Grant to MICHauto will support high-tech career paths and strengthen Michigan global competitiveness in the automotive, mobility, and technology industries
Read MoreWednesday, December 7, 2022
Gov. Whitmer Announces Axis Automation Creating 50 High-Tech Jobs in Walker, Building on State’s Efforts to Grow STEM Talent in Michigan
Read MoreWednesday, December 7, 2022
Small manufacturers throughout Michigan receive state support to adopt Industry 4.0 technologies
MEDC’s Industry 4.0 Technology Implementation Grant program providing 24 companies with up to 50 percent reimbursement for qualifying I4.0 technology implementation costs
Read MoreMonday, December 5, 2022
This Just In: Michigan Continues to Lead in Life Sciences with Latest $750M Investment from Pfizer
Investment further establishes the Kalamazoo site as one of the most technologically advanced science facilities in the world, expanding access to Pfizer’s breakthrough medicines
Read More